RMgmDB - Rodent Malaria genetically modified Parasites

Summary

RMgm-840
Malaria parasiteP. berghei
Genotype
DisruptedGene model (rodent): PBANKA_1332400; Gene model (P.falciparum): PF3D7_1469200; Gene product: shewanella-like protein phosphatase 1, putative (SHLP1)
Phenotype Fertilization and ookinete; Oocyst;
Last modified: 13 March 2013, 15:54
  *RMgm-840
Successful modificationThe parasite was generated by the genetic modification
The mutant contains the following genetic modification(s) Gene disruption
Reference (PubMed-PMID number) Reference 1 (PMID number) : 23434509
MR4 number
Parent parasite used to introduce the genetic modification
Rodent Malaria ParasiteP. berghei
Parent strain/lineP. berghei ANKA
Name parent line/clone P. berghei ANKA 2.34
Other information parent lineP. berghei ANKA 2.34 is a cloned, gametocyte producer line of the ANKA strain (PubMed: PMID: 15137943)
The mutant parasite was generated by
Name PI/ResearcherPatzewitz EM; Tewari R
Name Group/DepartmentCentre for Genetics and Genomics, School of Biology, Queens Medical Centre
Name InstituteUniversity of Nottingham
CityNottingham
CountryUK
Name of the mutant parasite
RMgm numberRMgm-840
Principal nameΔshlp1
Alternative name
Standardized name
Is the mutant parasite cloned after genetic modificationYes
Phenotype
Asexual blood stageNot different from wild type
Gametocyte/GameteNot different from wild type
Fertilization and ookineteStrongly reduced (55-60%) ookinete production. The motility of ookinetes that are produced is normal.
OocystStrongly reduced (55-60%) ookinete production. No oocysts are formed.
SporozoiteNot tested
Liver stageNot tested
Additional remarks phenotype

Mutant/mutation
The mutant lacks expression of shewanella-like protein phosphatase 1 (SHLP1).

Protein (function)
Bioinformatic analysis of the Plasmodium genome has revealed the presence of non-conventional protein phosphatases (PPs) containing kelch-like motifs as found in plant PPs and two bacterial Shewanella-like PPs (Shelphs or SHLP), both lacking orthologs in humans. SHLPs are related to the phosphoprotein phosphatase (PPP) family of serine/threonine PPs (STPs), span the eukaryote-prokaryote boundary, and are also present in plants, heterokonts, fungi, and some Protozoa.

Phenotype
Strongly reduced (55-60%) ookinete production. Evidence is presented that this reduction is not due parasite death or dedifferentiation of ookinetes before they reach full maturity at 24 hr. This suggests that SHLP1 plays an important (though not essential) role at an early stage in ookinete development and differentiation.
The motility of ookinetes that are produced is normal. No oocysts are formed. Evidence is presented for aberrant formation of micronemes in ookinetes.

Additional information
Analysis of a mutant expressing a GFP-tagged version of SHLP1 (RMgm-841) showed diffuse fluorescence staining in all parasite stages examined by microscopy with prominent staining in the asexual stages, the male gamete, and oocyst. Despite the presence of a predicted apicoplast targeting signal, the protein was found distributed non-uniformly throughout the parasite cytoplasm in all stages analyzed and co-localized with ER tracker Red, suggesting that SHLP1-GFP is located in the endoplasmic reticulum (ER).

Genetic crossing of mutant male gametes with wild type female gametes resulted in the formation of oocysts indicating normal fertility of mutant male gametes.

Other mutants
RMgm-841: a mutant expressing a GFP-tagged version of SHLP1.


  Disrupted: Mutant parasite with a disrupted gene
Details of the target gene
Gene Model of Rodent Parasite PBANKA_1332400
Gene Model P. falciparum ortholog PF3D7_1469200
Gene productshewanella-like protein phosphatase 1, putative
Gene product: Alternative nameSHLP1
Details of the genetic modification
Inducable system usedNo
Additional remarks inducable system
Type of plasmid/construct usedPlasmid double cross-over
PlasmoGEM (Sanger) construct/vector usedNo
Modified PlasmoGEM construct/vector usedNo
Plasmid/construct map
Plasmid/construct sequence
Restriction sites to linearize plasmid
Partial or complete disruption of the geneComplete
Additional remarks partial/complete disruption
Selectable marker used to select the mutant parasitetgdhfr
Promoter of the selectable markerpbdhfr
Selection (positive) procedurepyrimethamine
Selection (negative) procedureNo
Additional remarks genetic modification
Additional remarks selection procedure
Primer information: Primers used for amplification of the target sequences  Click to view information
Primer information: Primers used for amplification of the target sequences  Click to hide information
Sequence Primer 15'-CCCCGGGCCCGTTAATATTGAATAACGTTGTCAAC-3'
Additional information primer 1P0171
Sequence Primer 25'-GGGGAAGCTTCTATAGCTATAATTTTGCCATTCC-3'
Additional information primer 2P0172
Sequence Primer 35'-CCCCGAATTCCAGGAAAGTCAAACTAATTTGAACCCAG-3'
Additional information primer 3P0173
Sequence Primer 45'-GGGGTCTAGAGAACAGAATTTGTATGTGTGAATGTGATC-3'
Additional information primer 4P0174
Sequence Primer 5
Additional information primer 5
Sequence Primer 6
Additional information primer 6